 "Deseret News (Salt Lake City)")
|
Exhibit shows how Copley worked
|
CAMBRIDGE, Mass. -- When acclaimed American painter John Singleton
Copley died in England in 1815, he left in his studio an unfinished
canvas, light layers of paint barely concealing the gridlines that
guided his brush.
The uncompleted work gathered dust and grime over the decades and,
for much of the 20th century, remained in storage at Harvard, out of
the public eye.
Now, Harvard has restored "Monmouth Before James II" for an
exhibit called "Process and Paradox: The Historical ...
Related newspaper, magazine, and journal articles from HighBeam Research
|
FOGG EXHIBIT REVEALS THE TOIL BEHIND SOME COPLEY TREASURES
The Boston Globe
; "Struggle" is not a word generally associated with the paintings of John Singleton Copley. His portraits of 18th-century worthies look effortless. They have a silken perfection familiar to Boston audiences because the first phase of this native son's career was spent here and many of his works
|
|
|
At MFA, a Colonial cast of the rich and famous Copley's work celebrates Boston and its upper crust
The Boston Globe
; The new show of John Singleton Copley portraits at the Museum of Fine Arts opens with an installation that startles, not because of the portrait of Mrs. Richard Skinner that is its centerpiece, but because of the wallpaper. It's aqua and white stripes with flowers and ribbons, and it extends from
|
|
John R. Copley
The Patriot Ledger Quincy, MA
; CANTON - John R. Copley, 83, of Canton, an engineer for Emerson and Cummings in Canton for many years, died Monday at Cape Heritage Nursing and Rehabilitation Center in Sandwich after a long illness. Mr. Copley also was an independent consultant for Cummings Corp. after retiring. He served in the
|
|
|
Copley earnings, stock tumble
The Boston Globe
; Stock in Copley Pharmaceuticals Inc. sank to an all-time low yesterday after the company predicted that earnings for its fiscal third quarter would fall below earnings in the same period last year. The Canton company blamed the earnings shortfall in part on a $2 million pretax charge to cover
|
|
Director, in protest, quits Copley Pharmaceuticals.
The Boston Herald
; A director and major shareholder of Copley Pharmaceuticals Inc. has abruptly resigned. Agnes Varis issued a statement saying she left to protest Hoechst AG's management of Copley. Hoechst, based in Germany, owns 52 percent of the Canton company, according to regulatory filings. I believe that a
|
